Vimarsana
Biggest News Aggregation in the World

Page 2 - Samir Devani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Samir Devani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Samir Devani Today - Breaking & Trending Today

Valneva SE (NASDAQ:VALN) Q3 2022 Earnings Call Transcript - Vimarsana News

Valneva SE (NASDAQ:VALN) Q3 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates Call. At this time, all participants are in a listen-only mode.

Covid 19: French drugmaker Valneva in talks with potential partner on second-gen vaccines - Vimarsana News

Covid 19: French drugmaker Valneva in talks with potential partner on second-gen vaccines

French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new va..

Related Topics:
Samir DevaniEuropean Union
Valneva in talks with potential partner on second-gen C... - Vimarsana News

Valneva in talks with potential partner on second-gen C...

PARIS, Sept 26 (Reuters) - French drugmaker Valneva VLS.PA said on Monday it is in talks with a potential partner on producing an updated version of its Covid-19 vaccine that targets new variants of the disease, sending its shares up.

Valneva in talks with potential partner on second-gen COVID-19 vaccines - Vimarsana News

Valneva in talks with potential partner on second-gen COVID-19 vaccines

PARIS — French drugmaker Valneva said on Monday it is in talks with a potential partner on producing an updated version of its COVID-19 vaccine that targets…

Climate Change Puts Lyme Disease In Focus For France's Valneva After COVID Blow - Vimarsana News

Climate Change Puts Lyme Disease In Focus For France's Valneva After COVID Blow

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.